Searching for Essential Genes and Targeted Drugs Common to Breast Cancer and Osteoarthritis

Henley, S.J.; Ward, E.M.; Scott, S.; Ma, J.; Anderson, R.N.; Firth, A.U.; Thomas, C.C.; Islami, F.; Weir, H.K.; Lewis, D.R.; Sherman, R.L.; Wu, M.; Benard, V.B.; Richardson, L.C.; Jemal, A.; Cronin, K.; Kohler, B.A. Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer, 2020, 126(10), 2225-2249.
[http://dx.doi.org/10.1002/cncr.32802] [PMID: 32162336]

Siegel, R.L.; Miller, K.D.; Fuchs, H.E.; Jemal, A. Cancer Statistics, 2021. CA Cancer J. Clin., 2021, 71(1), 7-33.
[http://dx.doi.org/10.3322/caac.21654] [PMID: 33433946]

Arnedos, M.; Vicier, C.; Loi, S.; Lefebvre, C.; Michiels, S.; Bonnefoi, H.; Andre, F. Precision medicine for metastatic breast cancer-limitations and solutions. Nat. Rev. Clin. Oncol., 2015, 12(12), 693-704.
[http://dx.doi.org/10.1038/nrclinonc.2015.123] [PMID: 26196250]

Koboldt, D.C.; Fulton, R.S.; McLellan, M.D.; Schmidt, H.; Kalicki-Veizer, J.; McMichael, J.F.; Fulton, L.L.; Dooling, D.J.; Ding, L.; Mardis, E.R.; Wilson, R.K.; Ally, A.; Balasundaram, M.; Butterfield, Y.S.N.; Carlsen, R.; Carter, C.; Chu, A.; Chuah, E.; Chun, H.J.E.; Coope, R.J.N.; Dhalla, N.; Guin, R.; Hirst, C.; Hirst, M.; Holt, R.A.; Lee, D.; Li, H.Y.I.; Mayo, M.; Moore, R.A.; Mungall, A.J.; Pleasance, E.; Robertson, A.G.; Schein, J.E.; Shafiei, A.; Sipahimalani, P.; Slobodan, J.R.; Stoll, D.; Tam, A.; Thiessen, N.; Varhol, R.J.; Wye, N.; Zeng, T.; Zhao, Y.J.; Birol, I.; Jones, S.J.M.; Marra, M.A.; Cherniack, A.D.; Saksena, G.; Onofrio, R.C.; Pho, N.H.; Carter, S.L.; Schumacher, S.E.; Tabak, B.; Hernandez, B.; Gentry, J.; Nguyen, H.; Crenshaw, A.; Ardlie, K.; Beroukhim, R.; Winckler, W.; Getz, G.; Gabriel, S.B.; Meyerson, M.; Chin, L.; Park, P.J.; Kucherlapati, R.; Hoadley, K.A.; Auman, J.T.; Fan, C.; Turman, Y.J.; Shi, Y.; Li, L.; Topal, M.D.; He, X.P.; Chao, H.H.; Prat, A.; Silva, G.O.; Iglesia, M.D.; Zhao, W.; Usary, J.; Berg, J.S.; Adams, M.; Booker, J.; Wu, J.Y.; Gulabani, A.; Bodenheimer, T.; Hoyle, A.P.; Simons, J.V.; Soloway, M.G.; Mose, L.E.; Jefferys, S.R.; Balu, S.; Parker, J.S.; Hayes, D.N.; Perou, C.M.; Malik, S.; Mahurkar, S.; Shen, H.; Weisenberger, D.J.; Triche, T.; Lai, P.H.; Bootwalla, M.S.; Maglinte, D.T.; Berman, B.P.; Van den Berg, D.J.; Baylin, S.B.; Laird, P.W.; Creighton, C.J.; Donehower, L.A.; Getz, G.; Noble, M.; Voet, D.; Saksena, G.; Gehlenborg, N.; DiCara, D.; Zhang, J.H.; Zhang, H.L.; Wu, C.J.; Liu, S.Y.; Lawrence, M.S.; Zou, L.H.; Sivachenko, A.; Lin, P.; Stojanov, P.; Jing, R.; Cho, J.; Sinha, R.; Park, R.W.; Nazaire, M.D.; Robinson, J.; Thorvaldsdottir, H.; Mesirov, J.; Park, P.J.; Chin, L.; Reynolds, S.; Kreisberg, R.B.; Bernard, B.; Bressler, R.; Erkkila, T.; Lin, J.; Thorsson, V.; Zhang, W.; Shmulevich, I.; Ciriello, G.; Weinhold, N.; Schultz, N.; Gao, J.J.; Cerami, E.; Gross, B.; Jacobsen, A.; Sinha, R.; Aksoy, B.A.; Antipin, Y.; Reva, B.; Shen, R.L.; Taylor, B.S.; Ladanyi, M.; Sander, C.; Anur, P.; Spellman, P.T.; Lu, Y.L.; Liu, W.B.; Verhaak, R.R.G.; Mills, G.B.; Akbani, R.; Zhang, N.X.; Broom, B.M.; Casasent, T.D.; Wakefield, C.; Unruh, A.K.; Baggerly, K.; Coombes, K.; Weinstein, J.N.; Haussler, D.; Benz, C.C.; Stuart, J.M.; Benz, S.C.; Zhu, J.C.; Szeto, C.C.; Scott, G.K.; Yau, C.; Paul, E.O.; Carlin, D.; Wong, C.; Sokolov, A.; Thusberg, J.; Mooney, S.; Ng, S.; Goldstein, T.C.; Ellrott, K.; Grifford, M.; Wilks, C.; Ma, S.; Craft, B.; Yan, C.H.; Hu, Y.; Meerzaman, D.; Gastier-Foster, J.M.; Bowen, J.; Ramirez, N.C.; Black, A.D.; Pyatt, R.E.; White, P.; Zmuda, E.J.; Frick, J.; Lichtenberg, T.; Brookens, R.; George, M.M.; Gerken, M.A.; Harper, H.A.; Leraas, K.M.; Wise, L.J.; Tabler, T.R.; McAllister, C.; Barr, T.; Hart-Kothari, M.; Tarvin, K.; Saller, C.; Sandusky, G.; Mitchell, C.; Iacocca, M.V.; Brown, J.; Rabeno, B.; Czerwinski, C.; Petrelli, N.; Dolzhansky, O.; Abramov, M.; Voronina, O.; Potapova, O.; Marks, J.R.; Suchorska, W.M.; Murawa, D.; Kycler, W.; Ibbs, M.; Korski, K.; Spychala, A.; Murawa, P.; Brzezinski, J.J.; Perz, H.; Lazniak, R.; Teresiak, M.; Tatka, H.; Leporowska, E.; Bogusz-Czerniewicz, M.; Malicki, J.; Mackiewicz, A.; Wiznerowicz, M.; Le, X.V.; Kohl, B.; Tien, N.V.; Thorp, R.; Bang, N.V.; Sussman, H.; Phu, B.D.; Hajek, R.; Hung, N.P.; Tran, V.T.P.; Thang, H.Q.; Khan, K.Z.; Penny, R.; Mallery, D.; Curley, E.; Shelton, C.; Yena, P.; Ingle, J.N.; Couch, F.J.; Lingle, W.L.; King, T.A.; Gonzalez-Angulo, A.M.; Mills, G.B.; Dyer, M.D.; Liu, S.Y.; Meng, X.L.; Patangan, M.; Waldman, F.; Stoppler, H.; Rathmell, W.K.; Thorne, L.; Huang, M.; Boice, L.; Hill, A.; Morrison, C.; Gaudioso, C.; Bshara, W.; Daily, K.; Egea, S.C.; Pegram, M.D.; Gomez-Fernandez, C.; Dhir, R.; Bhargava, R.; Brufsky, A.; Shriver, C.D.; Hooke, J.A.; Campbell, J.L.; Mural, R.J.; Hu, H.; Somiari, S.; Larson, C.; Deyarmin, B.; Kvecher, L.; Kovatich, A.J.; Ellis, M.J.; King, T.A.; Hu, H.; Couch, F.J.; Mural, R.J.; Stricker, T.; White, K.; Olopade, O.; Ingle, J.N.; Luo, C.Q.; Chen, Y.Q.; Marks, J.R.; Waldman, F.; Wiznerowicz, M.; Bose, R.; Chang, L.W.; Beck, A.H.; Gonzalez-Angulo, A.M.; Pihl, T.; Jensen, M.; Sfeir, R.; Kahn, A.; Chu, A.; Kothiyal, P.; Wang, Z.N.; Snyder, E.; Pontius, J.; Ayala, B.; Backus, M.; Walton, J.; Baboud, J.; Berton, D.; Nicholls, M.; Srinivasan, D.; Raman, R.; Girshik, S.; Kigonya, P.; Alonso, S.; Sanbhadti, R.; Barletta, S.; Pot, D.; Sheth, M.; Demchok, J.A.; Shaw, K.R.M.; Yang, L.M.; Eley, G.; Ferguson, M.L.; Tarnuzzer, R.W.; Zhang, J.S.; Dillon, L.A.L.; Buetow, K.; Fielding, P.; Ozenberger, B.A.; Guyer, M.S.; Sofia, H.J.; Palchik, J.D.; Canc Genome Atlas, N. Comprehensive molecular portraits of human breast tumours. Nature, 2012, 490(7418), 61-70.
[http://dx.doi.org/10.1038/nature11412] [PMID: 23000897]

Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2021, 71(3), 209-249.
[http://dx.doi.org/10.3322/caac.21660] [PMID: 33538338]

Allemani, C.; Matsuda, T.; Di Carlo, V.; Harewood, R.; Matz, M. Nikšić, M.; Bonaventure, A.; Valkov, M.; Johnson, C.J.; Estève, J.; Ogunbiyi, O.J.; Azevedo e Silva, G.; Chen, W.Q.; Eser, S.; Engholm, G.; Stiller, C.A.; Monnereau, A.; Woods, R.R.; Visser, O.; Lim, G.H.; Aitken, J.; Weir, H.K.; Coleman, M.P.; Bouzbid, S.; Hamdi-Chérif, M.; Zaidi, Z.; Meguenni, K.; Regagba, D.; Bayo, S.; Cheick Bougadari, T.; Manraj, S.S.; Bendahhou, K.; Fabowale, A.; Bradshaw, D.; Somdyala, N.I.M.; Kumcher, I.; Moreno, F.; Calabrano, G.H.; Espinola, S.B.; Carballo Quintero, B.; Fita, R.; Diumenjo, M.C.; Laspada, W.D.; Ibañez, S.G.; Lima, C.A.; De Souza, P.C.F.; Del Pino, K.; Laporte, C.; Curado, M.P.; de Oliveira, J.C.; Veneziano, C.L.A.; Veneziano, D.B.; Latorre, M.R.D.O.; Tanaka, L.F.; Rebelo, M.S.; Santos, M.O.; Galaz, J.C.; Aparicio Aravena, M.; Sanhueza Monsalve, J.; Herrmann, D.A.; Vargas, S.; Herrera, V.M.; Uribe, C.J.; Bravo, L.E.; Garcia, L.S.; Arias-Ortiz, N.E.; Morantes, D.; Jurado, D.M.; Yépez Chamorro, M.C.; Delgado, S.; Ramirez, M.; Galán Alvarez, Y.H.; Torres, P.; Martínez-Reyes, F.; Jaramillo, L.; Quinto, R.; Castillo, J.; Mendoza, M.; Cueva, P.; Yépez, J.G.; Bhakkan, B.; Deloumeaux, J.; Joachim, C.; Macni, J.; Carrillo, R.; Shalkow, K.J.; Rivera, G.R.; Poquioma, E.; Tortolero-Luna, G.; Zavala, D.; Alonso, R.; Barrios, E.; Eckstrand, A.; Nikiforuk, C.; Noonan, G.; Turner, D.; Kumar, E.; Zhang, B.; McCrate, F.R.; Ryan, S.; MacIntyre, M.; Saint-Jacques, N.; Nishri, D.E.; McClure, C.A.; Vriends, K.A.; Kozie, S.; Stuart-Panko, H.; Freeman, T.; George, J.T.; Brockhouse, J.T.; O’Brien, D.K.; Holt, A.; Almon, L.; Kwong, S.; Morris, C.; Rycroft, R.; Mueller, L.; Phillips, C.E.; Brown, H.; Cromartie, B.; Schwartz, A.G.; Vigneau, F.; Levin, G.M.; Wohler, B.; Bayakly, R.; Ward, K.C.; Gomez, S.L.; McKinley, M.; Cress, R.; Green, M.D.; Miyagi, K.; Ruppert, L.P.; Lynch, C.F.; Huang, B.; Tucker, T.C.; Deapen, D.; Liu, L.; Hsieh, M.C.; Wu, X.C.; Schwenn, M.; Gershman, S.T.; Knowlton, R.C.; Alverson, G.; Copeland, G.E.; Bushhouse, S.; Rogers, D.B.; Jackson-Thompson, J.; Lemons, D.; Zimmerman, H.J.; Hood, M.; Roberts-Johnson, J.; Rees, J.R.; Riddle, B.; Pawlish, K.S.; Stroup, A.; Key, C.; Wiggins, C.; Kahn, A.R.; Schymura, M.J.; Radhakrishnan, S.; Rao, C.; Giljahn, L.K.; Slocumb, R.M.; Espinoza, R.E.; Khan, F.; Aird, K.G.; Beran, T.; Rubertone, J.J.; Slack, S.J.; Garcia, L.; Rousseau, D.L.; Janes, T.A.; Schwartz, S.M.; Bolick, S.W.; Hurley, D.M.; Whiteside, M.A.; Miller-Gianturco, P.; Williams, M.A.; Herget, K.; Sweeney, C.; Johnson, A.T.; Keitheri Cheteri, M.B.; Migliore Santiago, P.; Blankenship, S.E.; Farley, S.; Borchers, R.; Malicki, R.; Espinoza, J.R.; Grandpre, J.; Wilson, R.; Edwards, B.K.; Mariotto, A.; Lei, Y.; Wang, N.; Chen, J.S.; Zhou, Y.; He, Y.T.; Song, G.H.; Gu, X.P.; Mei, D.; Mu, H.J.; Ge, H.M.; Wu, T.H.; Li, Y.Y.; Zhao, D.L.; Jin, F.; Zhang, J.H.; Zhu, F.D.; Junhua, Q.; Yang, Y.L.; Jiang, C.X.; Biao, W.; Wang, J.; Li, Q.L.; Yi, H.; Zhou, X.; Dong, J.; Li, W.; Fu, F.X.; Liu, S.Z.; Chen, J.G.; Zhu, J.; Li, Y.H.; Lu, Y.Q.; Fan, M.; Huang, S.Q.; Guo, G.P.; Zhaolai, H.; Wei, K.; Zeng, H.; Demetriou, A.V.; Mang, W.K.; Ngan, K.C.; Kataki, A.C.; Krishnatreya, M.; Jayalekshmi, P.A.; Sebastian, P.; Nandakumar, A.; Malekzadeh, R.; Roshandel, G.; Keinan-Boker, L.; Silverman, B.G.; Ito, H.; Nakagawa, H.; Sato, M.; Tobori, F.; Nakata, I.; Teramoto, N.; Hattori, M.; Kaizaki, Y.; Moki, F.; Sugiyama, H.; Utada, M.; Nishimura, M.; Yoshida, K.; Kurosawa, K.; Nemoto, Y.; Narimatsu, H.; Sakaguchi, M.; Kanemura, S.; Naito, M.; Narisawa, R.; Miyashiro, I.; Nakata, K.; Sato, S.; Yoshii, M.; Oki, I.; Fukushima, N.; Shibata, A.; Iwasa, K.; Ono, C.; Nimri, O.; Jung, K.W.; Won, Y.J.; Alawadhi, E.; Elbasmi, A.; Ab Manan, A.; Adam, F.; Sanjaajmats, E.; Tudev, U.; Ochir, C.; Al Khater, A.M.; El Mistiri, M.M.; Teo, Y.Y.; Chiang, C.J.; Lee, W.C.; Buasom, R.; Sangrajrang, S.; Kamsa-ard, S.; Wiangnon, S.; Daoprasert, K.; Pongnikorn, D.; Leklob, A.; Sangkitipaiboon, S.; Geater, S.L.; Sriplung, H.; Ceylan, O.; Kög, I.; Dirican, O.; Köse, T.; Gurbuz, T.; Karaşahin, F.E.; Turhan, D.; Aktaş U.; Halat, Y.; Yakut, C.I.; Altinisik, M.; Cavusoglu, Y.; Türkköylü, A.; Üçüncü, N.; Hackl, M.; Zborovskaya, A.A.; Aleinikova, O.V.; Henau, K.; Van Eycken, L.; Valerianova, Z.; Yordanova, M.R.; Šekerija, M.; Dušek, L.; Zvolský, M.; Storm, H.; Innos, K.; Mägi, M.; Malila, N.; Seppä, K.; Jégu, J.; Velten, M.; Cornet, E.; Troussard, X.; Bouvier, A.M.; Guizard, A.V.; Bouvier, V.; Launoy, G.; Arveux, P.; Maynadié, M.; Mounier, M.; Woronoff, A.S.; Daoulas, M.; Robaszkiewicz, M.; Clavel, J.; Goujon, S.; Lacour, B.; Baldi, I.; Pouchieu, C.; Amadeo, B.; Coureau, G.; Orazio, S.; Preux, P.M.; Rharbaoui, F.; Marrer, E.; Trétarre, B.; Colonna, M.; Delafosse, P.; Ligier, K.; Plouvier, S.; Cowppli-Bony, A.; Molinié, F.; Bara, S.; Ganry, O.; Lapôtre-Ledoux, B.; Grosclaude, P.; Bossard, N.; Uhry, Z.; Bray, F.; Piñeros, M.; Stabenow, R.; Wilsdorf-Köhler, H.; Eberle, A.; Luttmann, S.; Löhden, I.; Nennecke, A.L.; Kieschke, J.; Sirri, E.; Emrich, K.; Zeissig, S.R.; Holleczek, B.; Eisemann, N.; Katalinic, A.; Asquez, R.A.; Kumar, V.; Petridou, E.; Ólafsdóttir, E.J.; Tryggvadóttir, L.; Clough-Gorr, K.; Walsh, P.M.; Sundseth, H.; Mazzoleni, G.; Vittadello, F.; Coviello, E.; Cuccaro, F.; Galasso, R.; Sampietro, G.; Giacomin, A.; Magoni, M.; Ardizzone, A.; D’Argenzio, A.; Castaing, M.; Grosso, G.; Lavecchia, A.M.; Sutera Sardo, A.; Gola, G.; Gatti, L.; Ricci, P.; Ferretti, S.; Serraino, D.; Zucchetto, A.; Celesia, M.V.; Filiberti, R.A.; Pannozzo, F.; Melcarne, A.; Quarta, F.; Russo, A.G.; Carrozzi, G.; Cirilli, C.; Cavalieri d’Oro, L.; Rognoni, M.; Fusco, M.; Vitale, M.F.; Usala, M.; Cusimano, R.; Mazzucco, W.; Michiara, M.; Sgargi, P.; Boschetti, L.; Borciani, E.; Seghini, P.; Maule, M.M.; Merletti, F.; Tumino, R.; Mancuso, P.; Vicentini, M.; Cassetti, T.; Sassatelli, R.; Falcini, F.; Giorgetti, S.; Caiazzo, A.L.; Cavallo, R.; Cesaraccio, R.; Pirino, D.R.; Contrino, M.L.; Tisano, F.; Fanetti, A.C.; Maspero, S.; Carone, S.; Mincuzzi, A.; Candela, G.; Scuderi, T.; Gentilini, M.A.; Piffer, S.; Rosso, S.; Barchielli, A.; Caldarella, A.; Bianconi, F.; Stracci, F.; Contiero, P.; Tagliabue, G.; Rugge, M.; Zorzi, M.; Beggiato, S.; Brustolin, A.; Berrino, F.; Gatta, G.; Sant, M.; Buzzoni, C.; Mangone, L.; Capocaccia, R.; De Angelis, R.; Zanetti, R.; Maurina, A.; Pildava, S.; Lipunova, N.; Vincerževskiené, I.; Agius, D.; Calleja, N.; Siesling, S.; Larønningen, S.; Møller, B.; Dyzmann-Sroka, A.; Trojanowski, M.; Góźdź, S.Mężyk, R.; Mierzwa, T.; Molong, L.; Rachtan, J.; Szewczyk, S.; BBłaszczyk, J.; Kępska, K.; Kościańska, B.; Tarocińska, K.; Zwierko, M.; Drosik, K.; Maksimowicz, K.M.; Purwin-Porowska, E.; Reca, E.; Wójcik-Tomaszewska, J.; Tukiendorf, A.; Grądalska-Lampart, M.; Radziszewska, A.U.; Gos, A.; Talerczyk, M.; Wyborska, M.; Didkowska, J.A.; Wojciechowska, U.; Bielska-Lasota, M.; Forjaz de Lacerda, G.; Rego, R.A.; Bastos, J.; Silva, M.A.; Antunes, L.; Laranja Pontes, J.; Mayer-da-Silva, A.; Miranda, A.; Blaga, L.M.; Coza, D.; Gusenkova, L.; Lazarevich, O.; Prudnikova, O.; Vjushkov, D.M.; Egorova, A.G.; Orlov, A.E.; Kudyakov, L.A.; Pikalova, L.V.; Adamcik, J.; Safaei Diba, C.; Primic-Žakelj, M.; Zadnik, V.; Larrañaga, N.; Lopez de Munain, A.; Herrera, A.A.; Redondas, R.; Marcos-Gragera, R.; Vilardell Gil, M.L.; Molina, E.; Sánchez Perez, M.J.; Franch Sureda, P.; Ramos Montserrat, M.; Chirlaque, M.D.; Navarro, C.; Ardanaz, E.E.; Guevara, M.M.; Fernández-Delgado, R.; Peris-Bonet, R.; Carulla, M.; Galceran, J.; Alberich, C.; Vicente-Raneda, M.; Khan, S.; Pettersson, D.; Dickman, P.; Avelina, I.; Staehelin, K.; Camey, B.; Bouchardy, C.; Schaffar, R.; Frick, H.; Herrmann, C.; Bulliard, J.L.; Maspoli-Conconi, M.; Kuehni, C.E.; Redmond, S.M.; Bordoni, A.; Ortelli, L.; Chiolero, A.; Konzelmann, I.; Matthes, K.L.; Rohrmann, S.; Broggio, J.; Rashbass, J.; Fitzpatrick, D.; Gavin, A.; Clark, D.I.; Deas, A.J.; Huws, D.W.; White, C.; Montel, L.; Rachet, B.; Turculet, A.D.; Stephens, R.; Chalker, E.; Phung, H.; Walton, R.; You, H.; Guthridge, S.; Johnson, F.; Gordon, P.; D’Onise, K.; Priest, K.; Stokes, B.C.; Venn, A.; Farrugia, H.; Thursfield, V.; Dowling, J.; Currow, D.; Hendrix, J.; Lewis, C. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet, 2018, 391(10125), 1023-1075.
[http://dx.doi.org/10.1016/S0140-6736(17)33326-3] [PMID: 29395269]

Tulotta, C.; Ottewell, P. The role of IL-1B in breast cancer bone metastasis. Endocr. Relat. Cancer, 2018, 25(7), R421-R434.
[http://dx.doi.org/10.1530/ERC-17-0309] [PMID: 29760166]

Chaffer, C.L.; San Juan, B.P.; Lim, E.; Weinberg, R.A. EMT, cell plasticity and metastasis. Cancer Metastasis Rev., 2016, 35(4), 645-654.
[http://dx.doi.org/10.1007/s10555-016-9648-7] [PMID: 27878502]

Karamanou, K.; Franchi, M.; Vynios, D.; Brézillon, S. Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator. Semin. Cancer Biol., 2020, 62, 125-133.
[http://dx.doi.org/10.1016/j.semcancer.2019.08.003] [PMID: 31401293]

Kalluri, R.; Weinberg, R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest., 2009, 119(6), 1420-1428.
[http://dx.doi.org/10.1172/JCI39104] [PMID: 19487818]

Kong, D.; Zhou, H.; Neelakantan, D.; Hughes, C.J.; Hsu, J.Y.; Srinivasan, R.R.; Lewis, M.T.; Ford, H.L. VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk. Oncogene, 2021, 40(5), 964-979.
[http://dx.doi.org/10.1038/s41388-020-01539-x] [PMID: 33299122]

Gupta, G.P. Massagué, J. Cancer metastasis: Building a framework. Cell, 2006, 127(4), 679-695.
[http://dx.doi.org/10.1016/j.cell.2006.11.001] [PMID: 17110329]

Davis, F.M.; Azimi, I.; Faville, R.A.; Peters, A.A.; Jalink, K.; Putney, J.W., Jr; Goodhill, G.J.; Thompson, E.W.; Roberts-Thomson, S.J.; Monteith, G.R. Induction of epithelial–mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. Oncogene, 2014, 33(18), 2307-2316.
[http://dx.doi.org/10.1038/onc.2013.187] [PMID: 23686305]

Zeng, K.; He, B.; Yang, B.B.; Xu, T.; Chen, X.; Xu, M.; Liu, X.; Sun, H.; Pan, Y.; Wang, S. The pro-metastasis effect of circANKS1B in breast cancer. Mol. Cancer, 2018, 17(1), 160.
[http://dx.doi.org/10.1186/s12943-018-0914-x] [PMID: 30454010]

Samuel, S.M.; Varghese, E.; Varghese, S.; Büsselberg, D. Challenges and perspectives in the treatment of diabetes associated breast cancer. Cancer Treat. Rev., 2018, 70, 98-111.
[http://dx.doi.org/10.1016/j.ctrv.2018.08.004] [PMID: 30130687]

Sin, A.; Tang, W.; Wen, C.Y.; Chung, S.K.; Chiu, K.Y. The emerging role of endothelin-1 in the pathogenesis of subchondral bone disturbance and osteoarthritis. Osteoarthr. Cartil., 2015, 23(4), 516-524.
[http://dx.doi.org/10.1016/j.joca.2014.11.002] [PMID: 25463446]

Astephen Wilson, J.L.; Kobsar, D. Osteoarthritis year in review 2020: Mechanics. Osteoarthr. Cartil., 2021, 29(2), 161-169.
[http://dx.doi.org/10.1016/j.joca.2020.12.009] [PMID: 33421562]

Jacob, L.; Kostev, K. Osteoarthritis and the incidence of fracture in the United Kingdom: A retrospective cohort study of 258,696 patients. Osteoarthr. Cartil., 2021, 29(2), 215-221.
[http://dx.doi.org/10.1016/j.joca.2020.12.006] [PMID: 33359250]

Glyn-Jones, S.; Palmer, A.J.R.; Agricola, R.; Price, A.J.; Vincent, T.L.; Weinans, H.; Carr, A.J. Osteoarthritis. Lancet, 2015, 386(9991), 376-387.
[http://dx.doi.org/10.1016/S0140-6736(14)60802-3] [PMID: 25748615]

Sharma, T.; Radosevich, J.A.; Pachori, G.; Mandal, C.C. A molecular view of pathological microcalcification in breast cancer. J. Mammary Gland Biol. Neoplasia, 2016, 21(1-2), 25-40.
[http://dx.doi.org/10.1007/s10911-015-9349-9] [PMID: 26769216]

Quigley, D.A.; Tahiri, A.; Lüders, T.; Riis, M.H.; Balmain, A.; Børresen-Dale, A.L.; Bukholm, I.; Kristensen, V. Age, estrogen, and immune response in breast adenocarcinoma and adjacent normal tissue. OncoImmunology, 2017, 6(11), e1356142.
[http://dx.doi.org/10.1080/2162402X.2017.1356142] [PMID: 29147603]

Clemenceau, A.; Michou, L.; Diorio, C.; Durocher, F. Breast cancer and microcalcifications: An osteoimmunological disorder? Int. J. Mol. Sci., 2020, 21(22), 8613.
[http://dx.doi.org/10.3390/ijms21228613] [PMID: 33203195]

Wagner, P.; Olsson, H.; Lidgren, L.; Robertsson, O.; Ranstam, J. Increased cancer risks among arthroplasty patients: 30year follow-up of the Swedish knee arthroplasty register. Eur. J. Cancer, 2011, 47(7), 1061-1071.
[http://dx.doi.org/10.1016/j.ejca.2010.11.023] [PMID: 21227681]

Ward, M.M.; Alehashemi, S. Risks of solid cancers in elderly persons with osteoarthritis or ankylosing spondylitis. Rheumatology, 2020, 59(12), 3817-3825.
[http://dx.doi.org/10.1093/rheumatology/keaa166] [PMID: 32442295]

Bonfiglio, R.; Scimeca, M.; Toschi, N.; Pistolese, C.A.; Giannini, E.; Antonacci, C.; Ciuffa, S.; Tancredi, V.; Tarantino, U.; Albonici, L.; Bonanno, E. Radiological, histological and chemical analysis of breast microcalcifications: Diagnostic value and biological significance. J. Mammary Gland Biol. Neoplasia, 2018, 23(1-2), 89-99.
[http://dx.doi.org/10.1007/s10911-018-9396-0] [PMID: 29744755]

Gnant, M.; Pfeiler, G.; Steger, G.G.; Egle, D.; Greil, R.; Fitzal, F.; Wette, V.; Balic, M.; Haslbauer, F.; Melbinger-Zeinitzer, E.; Bjelic-Radisic, V.; Jakesz, R.; Marth, C.; Sevelda, P.; Mlineritsch, B.; Exner, R.; Fesl, C.; Frantal, S.; Singer, C.F. Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol., 2019, 20(3), 339-351.
[http://dx.doi.org/10.1016/S1470-2045(18)30862-3] [PMID: 30795951]

Vetter, M.; Landin, J.; Szczerba, B.M.; Castro-Giner, F.; Gkountela, S.; Donato, C.; Krol, I.; Scherrer, R.; Balmelli, C.; Malinovska, A.; Zippelius, A.; Kurzeder, C.; Heinzelmann-Schwarz, V.; Weber, W.P.; Rochlitz, C.; Aceto, N. Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer. Breast Cancer Res., 2018, 20(1), 141.
[http://dx.doi.org/10.1186/s13058-018-1067-y] [PMID: 30458879]

Holen, I.; Lefley, D.V.; Francis, S.E.; Rennicks, S.; Bradbury, S.; Coleman, R.E.; Ottewell, P. IL-1 drives breast cancer growth and bone metastasis in vivo. Oncotarget, 2016, 7(46), 75571-75584.
[http://dx.doi.org/10.18632/oncotarget.12289] [PMID: 27765923]

Wu, T.C.; Xu, K.; Martinek, J.; Young, R.R.; Banchereau, R.; George, J.; Turner, J.; Kim, K.I.; Zurawski, S.; Wang, X.; Blankenship, D.; Brookes, H.M.; Marches, F.; Obermoser, G.; Lavecchio, E.; Levin, M.K.; Bae, S.; Chung, C.H.; Smith, J.L.; Cepika, A.M.; Oxley, K.L.; Snipes, G.J.; Banchereau, J.; Pascual, V.; O’Shaughnessy, J.; Palucka, A.K. IL1 receptor antagonist controls transcriptional signature of inflammation in patients with metastatic breast cancer. Cancer Res., 2018, 78(18), 5243-5258.
[http://dx.doi.org/10.1158/0008-5472.CAN-18-0413] [PMID: 30012670]

Tulotta, C.; Lefley, D.V.; Freeman, K.; Gregory, W.M.; Hanby, A.M.; Heath, P.R.; Nutter, F.; Wilkinson, J.M.; Spicer-Hadlington, A.R.; Liu, X.; Bradbury, S.M.J.; Hambley, L.; Cookson, V.; Allocca, G.; Kruithof de Julio, M.; Coleman, R.E.; Brown, J.E.; Holen, I.; Ottewell, P.D. Endogenous production of IL1B by breast cancer cells drives metastasis and colonization of the bone microenvironment. Clin. Cancer Res., 2019, 25(9), 2769-2782.
[http://dx.doi.org/10.1158/1078-0432.CCR-18-2202] [PMID: 30670488]

Rodriguez-Barrueco, R.; Yu, J.; Saucedo-Cuevas, L.P.; Olivan, M.; Llobet-Navas, D.; Putcha, P.; Castro, V.; Murga-Penas, E.M.; Collazo-Lorduy, A.; Castillo-Martin, M.; Alvarez, M.; Cordon-Cardo, C.; Kalinsky, K.; Maurer, M.; Califano, A.; Silva, J.M. Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR − /HER2 + breast cancers. Genes Dev., 2015, 29(15), 1631-1648.
[http://dx.doi.org/10.1101/gad.262642.115] [PMID: 26227964]

Alraouji, N.N.; Al-Mohanna, F.H.; Ghebeh, H.; Arafah, M.; Almeer, R.; Al-Tweigeri, T.; Aboussekhra, A. Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triplenegative breast cancer. Mol. Carcinog., 2020, 59(9), 1041-1051.
[http://dx.doi.org/10.1002/mc.23234] [PMID: 32537818]

Jin, K.; Pandey, N.B.; Popel, A.S. Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis. Breast Cancer Res., 2018, 20(1), 54.
[http://dx.doi.org/10.1186/s13058-018-0981-3] [PMID: 29898755]

Yan, J.; Qin, W.; Xiao, B.; Wan, Q.; Tay, F.R.; Niu, L.; Jiao, K. Pathological calcification in osteoarthritis: An outcome or a disease initiator? Biol. Rev. Camb. Philos. Soc., 2020, 95(4), 960-985.
[http://dx.doi.org/10.1111/brv.12595] [PMID: 32207559]

Scimeca, M.; Bonfiglio, R.; Menichini, E.; Albonici, L.; Urbano, N.; De Caro, M.T.; Mauriello, A.; Schillaci, O.; Gambacurta, A.; Bonanno, E. Microcalcifications drive breast cancer occurrence and development by macrophage-mediated epithelial to mesenchymal transition. Int. J. Mol. Sci., 2019, 20(22), 5633.
[http://dx.doi.org/10.3390/ijms20225633] [PMID: 31718020]

Hsiao, Y.W.; Lu, T.P. Text-mining in cancer research may help identify effective treatments. Transl. Lung Cancer Res., 2019, 8(S4), S460-S463.
[http://dx.doi.org/10.21037/tlcr.2019.12.20] [PMID: 32038938]

Zheng, S.; Dharssi, S.; Wu, M.; Li, J.; Lu, Z. Text mining for drug discovery. Methods Mol. Biol., 2019, 1939, 231-252.
[http://dx.doi.org/10.1007/978-1-4939-9089-4_13] [PMID: 30848465]

Isayev, O. Text mining facilitates materials discovery. Nature, 2019, 571(7763), 42-43.
[http://dx.doi.org/10.1038/d41586-019-01978-x] [PMID: 31270488]

Tao, D.; Yang, P.; Feng, H. Utilization of text mining as a big data analysis tool for food science and nutrition. Compr. Rev. Food Sci. Food Saf., 2020, 19(2), 875-894.
[http://dx.doi.org/10.1111/1541-4337.12540] [PMID: 33325182]

Wang, L.L.; Lo, K. Text mining approaches for dealing with the rapidly expanding literature on COVID-19. Brief. Bioinform., 2021, 22(2), 781-799.
[http://dx.doi.org/10.1093/bib/bbaa296] [PMID: 33279995]

Lee, J.; Yoon, W.; Kim, S.; Kim, D.; Kim, S.; So, C.H.; Kang, J. BioBERT: A pre-trained biomedical language representation model for biomedical text mining. Bioinformatics, 2020, 36(4), 1234-1240.
[http://dx.doi.org/10.1093/bioinformatics/btz682] [PMID: 31501885]

Wang, J.H.; Zhao, L.F.; Wang, H.F.; Wen, Y.T.; Jiang, K.K.; Mao, X.M.; Zhou, Z.Y.; Yao, K.T.; Geng, Q.S.; Guo, D.; Huang, Z.X. GenCLiP 3: Mining human genes’ functions and regulatory networks from PubMed based on co-occurrences and natural language processing. Bioinformatics, 2019, 36(6), btz807.
[http://dx.doi.org/10.1093/bioinformatics/btz807] [PMID: 31681951]

Wang, J.H.; Zhao, L.F.; Lin, P.; Su, X.R.; Chen, S.J.; Huang, L.Q.; Wang, H.F.; Zhang, H.; Hu, Z.F.; Yao, K.T.; Huang, Z.X. GenCLiP 2.0: A web server for functional clustering of genes and construction of molecular networks based on free terms. Bioinformatics, 2014, 30(17), 2534-2536.
[http://dx.doi.org/10.1093/bioinformatics/btu241] [PMID: 24764463]

Zhang, N.; Xu, W.; Wang, S.; Qiao, Y.; Zhang, X. Computational drug discovery in chemotherapy-induced alopecia via text mining and biomedical databases. Clin. Ther., 2019, 41(5), 972-980.e8.
[http://dx.doi.org/10.1016/j.clinthera.2019.04.003] [PMID: 31030996]

Kirk, J.; Shah, N.; Noll, B.; Stevens, C.B.; Lawler, M.; Mougeot, F.B.; Mougeot, J.L.C. Text mining-based in silico drug discovery in oral mucositis caused by high-dose cancer therapy. Support. Care Cancer, 2018, 26(8), 2695-2705.
[http://dx.doi.org/10.1007/s00520-018-4096-2] [PMID: 29476419]

Hu, D.; Jiang, J.; Lin, Z.; Zhang, C.; Moonasar, N.; Qian, S. Identification of key genes and pathways in scleral extracellular matrix remodeling in glaucoma: Potential therapeutic agents discovered using bioinformatics analysis. Int. J. Med. Sci., 2021, 18(7), 1554-1565.
[http://dx.doi.org/10.7150/ijms.52846] [PMID: 33746571]

Szklarczyk, D.; Gable, A.L.; Nastou, K.C.; Lyon, D.; Kirsch, R.; Pyysalo, S.; Doncheva, N.T.; Legeay, M.; Fang, T.; Bork, P.; Jensen, L.J.; von Mering, C. The STRING database in 2021: Customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res., 2021, 49(D1), D605-D612.
[http://dx.doi.org/10.1093/nar/gkaa1074] [PMID: 33237311]

Yi, L.; Wu, G.; Guo, L.; Zou, X.; Huang, P. Comprehensive analysis of the PD-L1 and immune infiltrates of m6A RNA methylation regulators in head and neck squamous cell carcinoma. Mol. Ther. Nucleic Acids, 2020, 21, 299-314.
[http://dx.doi.org/10.1016/j.omtn.2020.06.001] [PMID: 32622331]

Koh, Y.W.; Han, J.H.; Haam, S.; Jung, J.; Lee, H.W. Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients. OncoImmunol., 2019, 8(10), e1629261.
[http://dx.doi.org/10.1080/2162402X.2019.1629261] [PMID: 31646074]

Hoadley, K.A.; Yau, C.; Wolf, D.M.; Cherniack, A.D.; Tamborero, D.; Ng, S.; Leiserson, M.D.M.; Niu, B.; McLellan, M.D.; Uzunangelov, V.; Zhang, J.; Kandoth, C.; Akbani, R.; Shen, H.; Omberg, L.; Chu, A.; Margolin, A.A.; van’t Veer, L.J.; Lopez-Bigas, N.; Laird, P.W.; Raphael, B.J.; Ding, L.; Robertson, A.G.; Byers, L.A.; Mills, G.B.; Weinstein, J.N.; Van Waes, C.; Chen, Z.; Collisson, E.A.; Benz, C.C.; Perou, C.M.; Stuart, J.M. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell, 2014, 158(4), 929-944.
[http://dx.doi.org/10.1016/j.cell.2014.06.049] [PMID: 25109877]

Iglesia, M.D.; Parker, J.S.; Hoadley, K.A.; Serody, J.S.; Perou, C.M.; Vincent, B.G. Genomic analysis of immune cell infiltrates across 11 tumor types. J. Natl. Cancer Inst., 2016, 108(11), djw144.
[http://dx.doi.org/10.1093/jnci/djw144] [PMID: 27335052]

Zhou, Y.; Zhou, B.; Pache, L.; Chang, M.; Khodabakhshi, A.H.; Tanaseichuk, O.; Benner, C.; Chanda, S.K. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun., 2019, 10(1), 1523.
[http://dx.doi.org/10.1038/s41467-019-09234-6] [PMID: 30944313]

Tang, Z.; Li, C.; Kang, B.; Gao, G.; Li, C.; Zhang, Z. GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res., 2017, 45(W1), W98-W102.
[http://dx.doi.org/10.1093/nar/gkx247] [PMID: 28407145]

Tang, Z.; Kang, B.; Li, C.; Chen, T.; Zhang, Z. GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res., 2019, 47(W1), W556-W560.
[http://dx.doi.org/10.1093/nar/gkz430] [PMID: 31114875]

Li, C.; Tang, Z.; Zhang, W.; Ye, Z.; Liu, F. GEPIA2021: Integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res., 2021, 49(W1), W242-W246.
[http://dx.doi.org/10.1093/nar/gkab418] [PMID: 34050758]

Cotto, K.C.; Wagner, A.H.; Feng, Y.Y.; Kiwala, S.; Coffman, A.C.; Spies, G.; Wollam, A.; Spies, N.C.; Griffith, O.L.; Griffith, M. DGIdb 3.0: A redesign and expansion of the drug–gene interaction database. Nucleic Acids Res., 2018, 46(D1), D1068-D1073.
[http://dx.doi.org/10.1093/nar/gkx1143] [PMID: 29156001]

Wishart, D.S.; Feunang, Y.D.; Guo, A.C.; Lo, E.J.; Marcu, A.; Grant, J.R.; Sajed, T.; Johnson, D.; Li, C.; Sayeeda, Z.; Assempour, N.; Iynkkaran, I.; Liu, Y.; Maciejewski, A.; Gale, N.; Wilson, A.; Chin, L.; Cummings, R.; Le, D.; Pon, A.; Knox, C.; Wilson, M. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res., 2018, 46(D1), D1074-D1082.
[http://dx.doi.org/10.1093/nar/gkx1037] [PMID: 29126136]

Nelson, A.E.; Allen, K.D.; Golightly, Y.M.; Goode, A.P.; Jordan, J.M. A systematic review of recommendations and guidelines for the management of osteoarthritis: The Chronic Osteoarthritis Management Initiative of the U.S. Bone and Joint Initiative. Semin. Arthritis Rheum., 2014, 43(6), 701-712.
[http://dx.doi.org/10.1016/j.semarthrit.2013.11.012] [PMID: 24387819]

Block, J.A. OA guidelines: Improving care or merely codifying practice? Nat. Rev. Rheumatol., 2014, 10(6), 324-326.
[http://dx.doi.org/10.1038/nrrheum.2014.61] [PMID: 24752185]

Hunter, D.J.; Bierma-Zeinstra, S. Osteoarthritis. Lancet, 2019, 393(10182), 1745-1759.
[http://dx.doi.org/10.1016/S0140-6736(19)30417-9] [PMID: 31034380]

Ferguson, R.J.; Palmer, A.J.R.; Taylor, A.; Porter, M.L.; Malchau, H.; Glyn-Jones, S. Hip replacement. Lancet, 2018, 392(10158), 1662-1671.
[http://dx.doi.org/10.1016/S0140-6736(18)31777-X] [PMID: 30496081]

Carr, A.J.; Robertsson, O.; Graves, S.; Price, A.J.; Arden, N.K.; Judge, A.; Beard, D.J. Knee replacement. Lancet, 2012, 379(9823), 1331-1340.
[http://dx.doi.org/10.1016/S0140-6736(11)60752-6] [PMID: 22398175]

Smith-Turchyn, J.; Mukherjee, S.; Richardson, J.; Ball, E.; Bordeleau, L.; Neil-Sztramko, S.; Levine, O.; Thabane, L.; Sathiyapalan, A.; Sabiston, C. Evaluation of a novel strategy to implement exercise evidence into clinical practice in breast cancer care: protocol for the NEXT-BRCA randomised controlled trial. BMJ Open Sport Exerc. Med., 2020, 6(1), e000922.
[http://dx.doi.org/10.1136/bmjsem-2020-000922] [PMID: 33178447]

Furmaniak, A.C.; Menig, M.; Markes, M.H. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Libr., 2016, 2016(9), CD005001.
[http://dx.doi.org/10.1002/14651858.CD005001.pub3] [PMID: 27650122]

Ferket, B.S.; Feldman, Z.; Zhou, J.; Oei, E.H.; Bierma-Zeinstra, S.M.A.; Mazumdar, M. Impact of total knee replacement practice: cost effectiveness analysis of data from the Osteoarthritis Initiative. BMJ, 2017, 356, j1131.
[http://dx.doi.org/10.1136/bmj.j1131] [PMID: 28351833]

Tankó, L.B.; Søndergaard, B.C.; Oestergaard, S.; Karsdal, M.A.; Christiansen, C. An update review of cellular mechanisms conferring the indirect and direct effects of estrogen on articular cartilage. Climacteric, 2008, 11(1), 4-16.
[http://dx.doi.org/10.1080/13697130701857639] [PMID: 18202960]

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials. Lancet, 2015, 386(10001), 1341-1352.
[http://dx.doi.org/10.1016/S0140-6736(15)61074-1] [PMID: 26211827]

Goldvaser, H.; Barnes, T.A.; Šeruga, B.; Cescon, D.W.; Ocaña, A.; Ribnikar, D.; Amir, E. Toxicity of extended adjuvant therapy with aromatase inhibitors in early breast cancer: A systematic review and meta-analysis. J. Natl. Cancer Inst., 2018, 110(1), 31-39.
[http://dx.doi.org/10.1093/jnci/djx141] [PMID: 28922781]

Coleman, R.; Body, J.J.; Aapro, M.; Hadji, P.; Herrstedt, J. Bone health in cancer patients. ESMO Clinical Practice Guidelines. Ann. Oncol., 2014, 25(S3), iii124-iii137.
[http://dx.doi.org/10.1093/annonc/mdu103] [PMID: 24782453]

Shapiro, C.L.; Recht, A. Late effects of adjuvant therapy for breast cancer. J. Natl. Cancer Inst. Monogr., 1994, (16), 101-112. [PMID: 7999452

Henry, N.L.; Giles, J.T.; Ang, D.; Mohan, M.; Dadabhoy, D.; Robarge, J.; Hayden, J.; Lemler, S.; Shahverdi, K.; Powers, P.; Li, L.; Flockhart, D.; Stearns, V.; Hayes, D.F.; Storniolo, A.M.; Clauw, D.J. Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors. Breast Cancer Res. Treat., 2008, 111(2), 365-372.
[http://dx.doi.org/10.1007/s10549-007-9774-6] [PMID: 17922185]

Mao, J.J.; Stricker, C.; Bruner, D.; Xie, S.; Bowman, M.A.; Farrar, J.T.; Greene, B.T.; DeMichele, A. Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer, 2009, 115(16), 3631-3639.
[http://dx.doi.org/10.1002/cncr.24419] [PMID: 19517460]

Milstone, Z.J.; Lawson, G.; Trivedi, C.M. Histone deacetylase 1 and 2 are essential for murine neural crest proliferation, pharyngeal arch development, and craniofacial morphogenesis. Dev. Dyn., 2017, 246(12), 1015-1026.
[http://dx.doi.org/10.1002/dvdy.24563] [PMID: 28791750]

Krämer, O.H. HDAC2: A critical factor in health and disease. Trends Pharmacol. Sci., 2009, 30(12), 647-655.
[http://dx.doi.org/10.1016/j.tips.2009.09.007] [PMID: 19892411]

Riccio, A. New endogenous regulators of class I histone deacetylases. Sci. Signal., 2010, 3(103), pe1.
[http://dx.doi.org/10.1126/scisignal.3103pe1] [PMID: 20051592]

Lee, Y.H.; Seo, D.; Choi, K.J.; Andersen, J.B.; Won, M.A.; Kitade, M.; Gómez-Quiroz, L.E.; Judge, A.D.; Marquardt, J.U.; Raggi, C.; Conner, E.A.; MacLachlan, I.; Factor, V.M.; Thorgeirsson, S.S. Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2. Cancer Res., 2014, 74(17), 4752-4761.
[http://dx.doi.org/10.1158/0008-5472.CAN-13-3531] [PMID: 24958469]

Kiweler, N.; Brill, B.; Wirth, M.; Breuksch, I.; Laguna, T.; Dietrich, C.; Strand, S.; Schneider, G.; Groner, B.; Butter, F.; Heinzel, T.; Brenner, W.; Krämer, O.H. The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells. Arch. Toxicol., 2018, 92(7), 2227-2243.
[http://dx.doi.org/10.1007/s00204-018-2229-5] [PMID: 29845424]

Huang, W.T.; Tsai, Y.H.; Chen, S.H.; Kuo, C.W.; Kuo, Y.L.; Lee, K.T.; Chen, W.C.; Wu, P.C.; Chuang, C.Y.; Cheng, S.M.; Lin, C.H.; Leung, E.Y.; Chang, Y.C.; Cheung, C.H.A. HDAC2 and HDAC5 up-regulations modulate survivin and miR-125a-5p expressions and promote hormone therapy resistance in estrogen receptor positive breast cancer cells. Front. Pharmacol., 2017, 8, 902.
[http://dx.doi.org/10.3389/fphar.2017.00902] [PMID: 29326587]

Darvishi, N.; Rahimi, K.; Mansouri, K.; Fathi, F.; Menbari, M.N.; Mohammadi, G.; Abdi, M. MiR-646 prevents proliferation and progression of human breast cancer cell lines by suppressing HDAC2 expression. Mol. Cell. Probes, 2020, 53, 101649.
[http://dx.doi.org/10.1016/j.mcp.2020.101649] [PMID: 32777446]

Bayat, S.; Mansoori, D.S.; Mansoori, D.N.; Shekari, K.M.; Alivand, M.R. Downregulation of HDAC2 and HDAC3via oleuropein as a potent prevention and therapeutic agent in MCF-7 breast cancer cells. J. Cell. Biochem., 2019, 120(6), 9172-9180.
[http://dx.doi.org/10.1002/jcb.28193] [PMID: 30618185]

Zhang, N.; Zhang, H.; Liu, Y.; Su, P.; Zhang, J.; Wang, X.; Sun, M.; Chen, B.; Zhao, W.; Wang, L.; Wang, H.; Moran, M.S.; Haffty, B.G.; Yang, Q. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2. Cell Death Differ., 2019, 26(5), 843-859.
[http://dx.doi.org/10.1038/s41418-018-0158-8] [PMID: 29988076]

Zhang, Z.; Qiu, N.; Yin, J.; Zhang, J.; Liu, H.; Guo, W.; Liu, M.; Liu, T.; Chen, D.; Luo, K.; Li, H.; He, Z.; Liu, J.; Zheng, G. SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression. Theranostics, 2020, 10(10), 4290-4307.
[http://dx.doi.org/10.7150/thno.41008] [PMID: 32292495]

Roy, S.S.; Gonugunta, V.K.; Bandyopadhyay, A.; Rao, M.K.; Goodall, G.J.; Sun, L-Z.; Tekmal, R.R.; Vadlamudi, R.K. Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer. Oncogene, 2014, 33(28), 3707-3716.
[http://dx.doi.org/10.1038/onc.2013.332] [PMID: 23975430]

Fu, J.; Qin, L.; He, T.; Qin, J.; Hong, J.; Wong, J.; Liao, L.; Xu, J. The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis. Cell Res., 2011, 21(2), 275-289.
[http://dx.doi.org/10.1038/cr.2010.118] [PMID: 20714342]

Wang, Z.; Zhou, N.; Wang, W.; Yu, Y.; Xia, L.; Li, N. HDAC2 interacts with microRNA-503-5p to regulate SGK1 in osteoarthritis. Arthritis Res. Ther., 2021, 23(1), 78.
[http://dx.doi.org/10.1186/s13075-020-02373-y] [PMID: 33750441]

Mao, G.; Zhang, Z.; Huang, Z.; Chen, W.; Huang, G.; Meng, F.; Zhang, Z.; Kang, Y. MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation. Osteoarthr. Cartil., 2017, 25(4), 521-532.
[http://dx.doi.org/10.1016/j.joca.2016.11.006] [PMID: 27884646]

Culley, K.L.; Hui, W.; Barter, M.J.; Davidson, R.K.; Swingler, T.E.; Destrument, A.P.M.; Scott, J.L.; Donell, S.T.; Fenwick, S.; Rowan, A.D.; Young, D.A.; Clark, I.M. Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation. Arthritis Rheum., 2013, 65(7), 1822-1830.
[http://dx.doi.org/10.1002/art.37965] [PMID: 23575963]

van Tilborg, A.A.G.; de Vries, A.; Zwarthoff, E.C. The chromosome 9q genesTGFBR1,TSC1, andZNF189 are rarely mutated in bladder cancer. J. Pathol., 2001, 194(1), 76-80.
[http://dx.doi.org/10.1002/path.860] [PMID: 11329144]

Daley, D.; Morgan, W.; Lewis, S.; Willis, J.; Elston, R.C.; Markowitz, S.D.; Wiesner, G.L. Is TGFBR1*6A a susceptibility allele for nonsyndromic familial colorectal neoplasia? Cancer Epidemiol. Biomarkers Prev., 2007, 16(5), 892-894.
[http://dx.doi.org/10.1158/1055-9965.EPI-06-0965] [PMID: 17507611]

Bose, S.; Morgan, L.J.; Booth, D.R.; Goudie, D.R.; Ferguson-Smith, M.A.; Richards, F.M. The elusive multiple self-healing squamous epithelioma (MSSE) gene: Further mapping, analysis of candidates, and loss of heterozygosity. Oncogene, 2006, 25(5), 806-812.
[http://dx.doi.org/10.1038/sj.onc.1209092] [PMID: 16170343]

Siegel, P.M.; Massagué, J. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer, 2003, 3(11), 807-820.
[http://dx.doi.org/10.1038/nrc1208] [PMID: 14557817]

Pasche, B.; Knobloch, T.J.; Bian, Y.; Liu, J.; Phukan, S.; Rosman, D.; Kaklamani, V.; Baddi, L.; Siddiqui, F.S.; Frankel, W.; Prior, T.W.; Schuller, D.E.; Agrawal, A.; Lang, J.; Dolan, M.E.; Vokes, E.E.; Lane, W.S.; Huang, C.C.; Caldes, T.; Di Cristofano, A.; Hampel, H.; Nilsson, I.; von Heijne, G.; Fodde, R.; Murty, V.V.; de la Chapelle, A.; Weghorst, C.M. Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA, 2005, 294(13), 1634-1646.
[http://dx.doi.org/10.1001/jama.294.13.1634] [PMID: 16204663]

Lei, B.; Wang, D.; Zhang, M.; Deng, Y.; Jiang, H.; Li, Y. miR-615-3p promotes the epithelial-mesenchymal transition and metastasis of breast cancer by targeting PICK1/TGFBRI axis. J. Exp. Clin. Cancer Res., 2020, 39(1), 71.
[http://dx.doi.org/10.1186/s13046-020-01571-5] [PMID: 32336285]

Schmierer, B.; Hill, C.S. TGFβ–SMAD signal transduction: Molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol., 2007, 8(12), 970-982.
[http://dx.doi.org/10.1038/nrm2297] [PMID: 18000526]

Wrana, J.L.; Attisano, L.; Wieser, R.; Ventura, F.; Massagué, J. Mechanism of activation of the TGF-β receptor. Nature, 1994, 370(6488), 341-347.
[http://dx.doi.org/10.1038/370341a0] [PMID: 8047140]

Liu, Y.Y.; Zhang, S.; Yu, T.J.; Zhang, F.L.; Yang, F.; Huang, Y.N.; Ma, D.; Liu, G.Y.; Shao, Z.M.; Li, D.Q. Pregnancy-specific glycoprotein 9 acts as both a transcriptional target and a regulator of the canonical TGF‐β/Smad signaling to drive breast cancer progression. Clin. Transl. Med., 2020, 10(8), e245.
[http://dx.doi.org/10.1002/ctm2.245] [PMID: 33377651]

Park, C.Y.; Son, J.Y.; Jin, C.H.; Nam, J.S.; Kim, D.K.; Sheen, Y.Y. EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung. Eur. J. Cancer, 2011, 47(17), 2642-2653.
[http://dx.doi.org/10.1016/j.ejca.2011.07.007] [PMID: 21852112]

Wang, S.; Huang, M.; Wang, Z.; Wang, W.; Zhang, Z.; Qu, S.; Liu, C. MicroRNA 133b targets TGF‐β receptor I to inhibit TGF‐β-induced epithelial to mesenchymal transition and metastasis by suppressing the TGF‐β/SMAD pathway in breast cancer. Int. J. Oncol., 2019, 55(5), 1097-1109.
[http://dx.doi.org/10.3892/ijo.2019.4879] [PMID: 31545407]

Wu, Y.; Tran, T.; Dwabe, S.; Sarkissyan, M.; Kim, J.; Nava, M.; Clayton, S.; Pietras, R.; Farias-Eisner, R.; Vadgama, J.V. A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells. Breast Cancer Res. Treat., 2017, 163(3), 449-460.
[http://dx.doi.org/10.1007/s10549-017-4211-y] [PMID: 28337662]

Liu, W.; Feng, M.; Jayasuriya, C.T.; Peng, H.; Zhang, L.; Guan, Y.; Froehlich, J.A.; Terek, R.M.; Chen, Q. Human osteoarthritis cartilage-derived stromal cells activate joint degeneration through TGF-beta lateral signaling. FASEB J., 2020, 34(12), 16552-16566.
[http://dx.doi.org/10.1096/fj.202001448R] [PMID: 33118211]

Li, Z.; Kupcsik, L.; Yao, S.J.; Alini, M.; Stoddart, M.J. Mechanical load modulates chondrogenesis of human mesenchymal stem cells through the TGF-β pathway. J. Cell. Mol. Med., 2010, 14(6a), 1338-1346.
[http://dx.doi.org/10.1111/j.1582-4934.2009.00780.x] [PMID: 19432813]

Blaney Davidson, E.N.; Vitters, E.L.; van der Kraan, P.M.; van den Berg, W.B. Expression of transforming growth factor- (TGF) and the TGF signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation. Ann. Rheum. Dis., 2006, 65(11), 1414-1421.
[http://dx.doi.org/10.1136/ard.2005.045971] [PMID: 16439443]

Dong, M.; Ning, Z.Q.; Xing, P.Y.; Xu, J.L.; Cao, H.X.; Dou, G.F.; Meng, Z.Y.; Shi, Y.K.; Lu, X.P.; Feng, F.Y. Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas. Cancer Chemother. Pharmacol., 2012, 69(6), 1413-1422.
[http://dx.doi.org/10.1007/s00280-012-1847-5] [PMID: 22362161]

Ning, Z.Q.; Li, Z.B.; Newman, M.J.; Shan, S.; Wang, X.H.; Pan, D.S.; Zhang, J.; Dong, M.; Du, X.; Lu, X.P. Chidamide (CS055/HBI-8000): A new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity. Cancer Chemother. Pharmacol., 2012, 69(4), 901-909.
[http://dx.doi.org/10.1007/s00280-011-1766-x] [PMID: 22080169]

Lu, X.; Ning, Z.; Li, Z.; Cao, H.; Wang, X. Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China. Intractable Rare Dis. Res., 2016, 5(3), 185-191.
[http://dx.doi.org/10.5582/irdr.2016.01024] [PMID: 27672541]

Gao, S.; Li, X.; Zang, J.; Xu, W.; Zhang, Y. Preclinical and clinical studies of chidamide (CS055/HBI-8000), An orally available subtype-selective HDAC inhibitor for cancer therapy. Anticancer. Agents Med. Chem., 2017, 17(6), 802-812. [PMID: 27592546

Lazarova, D.; Bordonaro, M. ZEB1 mediates drug resistance and EMT in p300-Deficient CRC. J. Cancer, 2017, 8(8), 1453-1459.
[http://dx.doi.org/10.7150/jca.18762] [PMID: 28638460]

Su, Y.; Hopfinger, N.R.; Nguyen, T.D.; Pogash, T.J.; Santucci-Pereira, J.; Russo, J. Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors. J. Exp. Clin. Cancer Res., 2018, 37(1), 314.
[http://dx.doi.org/10.1186/s13046-018-0988-8] [PMID: 30547810]

Tsiftsoglou, A.S.; Bonovolias, I.D.; Tsiftsoglou, S.A. Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy. Pharmacol. Ther., 2009, 122(3), 264-280.
[http://dx.doi.org/10.1016/j.pharmthera.2009.03.001] [PMID: 19306896]

Salvador, M.A.; Wicinski, J.; Cabaud, O.; Toiron, Y.; Finetti, P.; Josselin, E.; Lelièvre, H.; Kraus-Berthier, L.; Depil, S.; Bertucci, F.; Collette, Y.; Birnbaum, D.; Charafe-Jauffret, E.; Ginestier, C. The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression. Clin. Cancer Res., 2013, 19(23), 6520-6531.
[http://dx.doi.org/10.1158/1078-0432.CCR-13-0877] [PMID: 24141629]

Hii, L.W.; Chung, F.F.L.; Soo, J.S.S.; Tan, B.S.; Mai, C.W.; Leong, C.O. Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously. Breast Cancer Res. Treat., 2020, 179(3), 615-629.
[http://dx.doi.org/10.1007/s10549-019-05504-5] [PMID: 31784862]

Zhang, Q.; Wang, T.; Geng, C.; Zhang, Y.; Zhang, J.; Ning, Z.; Jiang, Z. Exploratory clinical study of chidamide, an oral subtypeselective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer. Chin. J. Cancer Res., 2018, 30(6), 605-612.
[http://dx.doi.org/10.21147/j.issn.1000-9604.2018.06.05] [PMID: 30700929]